|
Mr. Noble serves on the supervisory board of MediGene AG, and prior to that was Chief Executive Officer of Avidex Ltd., in Oxford, UK. Mr. Noble currently serves on the board of GW Pharmaceuticals PLC and is non-executive director of Bionex Investments plc, and of Finsbury Worldwide Pharmaceutical Trust plc. Previously, Mr. Noble has served as a non-executive director of Powderject Pharmaceuticals PLC, Oxford Glycosciences plc, Advanced Medical Solutions plc, Oxagen Limited, Adprotech Pharmaceuticals Inc., Anthra Pharmaceuticals Inc., PAA GmbH, Prolifix Limited, and Neurovex Limited. From 1990 to 1997, Mr. Noble served as the Chief Financial Officer of British Biotech plc, and prior to that spent seven years at Kleinwert Benson Limited becoming a director in 1990. Mr. Noble previously qualified as a Chartered Accountant with Price Waterhouse in 1983 after graduating from Oxford University in 1980.
| 